Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5.
Both mast cells and complement participate in innate and acquired immunity. The current study examines whether beta-tryptase, the major protease of human mast cells, can directly generate bioactive complement anaphylatoxins. Important variables included pH, monomeric vs tetrameric forms of beta-tryptase, and the beta-tryptase-activating polyanion. The B12 mAb was used to stabilize beta-tryptase in its monomeric form. C3a and C4a were best generated from C3 and C4, respectively, by monomeric beta-tryptase in the presence of low molecular weight dextran sulfate or heparin at acidic pH. High molecular weight polyanions increased degradation of these anaphylatoxins. C5a was optimally generated from C5 at acidic pH by beta-tryptase monomers in the presence of high molecular weight dextran sulfate and heparin polyanions, but also was produced by beta-tryptase tetramers under these conditions. Mass spectrometry verified that the molecular mass of each anaphylatoxin was correct. Both beta-tryptase-generated C5a and C3a (but not C4a) were potent activators of human skin mast cells. These complement anaphylatoxins also could be generated by beta-tryptase in releasates of activated skin mast cells. Of further biologic interest, beta-tryptase also generated C3a from C3 in human plasma at acidic pH. These results suggest beta-tryptase might generate complement anaphylatoxins in vivo at sites of inflammation, such as the airway of active asthma patients where the pH is acidic and where elevated levels of beta-tryptase and complement anaphylatoxins are detected.
Fukuoka
Yoshihiro
Y
Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Xia
Han-Zhang
HZ
Sanchez-Muñoz
Laura B
LB
Dellinger
Anthony L
AL
Escribano
Luis
L
Schwartz
Lawrence B
LB
D000706:Anaphylatoxins / Q000096:biosynthesis* / Q000737:chemistry; D000911:Antibodies, Monoclonal / Q000737:chemistry; D001249:Asthma / Q000201:enzymology; D003176:Complement C3 / Q000737:chemistry / Q000378:metabolism*; D003181:Complement C4 / Q000737:chemistry / Q000378:metabolism*; D003182:Complement C5 / Q000737:chemistry / Q000378:metabolism*; D016264:Dextran Sulfate / Q000737:chemistry / Q000378:metabolism; D006493:Heparin / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007113:Immunity, Innate; D008407:Mast Cells / Q000737:chemistry / Q000378:metabolism*; D020836:Protein Structure, Quaternary; D012867:Skin / Q000737:chemistry / Q000378:metabolism; D053802:Tryptases / Q000737:chemistry / Q000378:metabolism*
D000706:Anaphylatoxins; D000911:Antibodies, Monoclonal; D003176:Complement C3; D003181:Complement C4; D003182:Complement C5; D006493:Heparin; D016264:Dextran Sulfate; D053802:Tryptases